Enovis (ENOV) Competitors

Enovis (NYSE:ENOV) and Penumbra (NYSE:PEN) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Is ENOV or PEN more profitable?

Penumbra has a net margin of 2.97% compared to Enovis' net margin of -5.95%. Penumbra's return on equity of 8.99% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Enovis	-5.95%	4.39%	2.80%
Penumbra	2.97%	8.99%	6.80%

Which has more volatility and risk, ENOV or PEN?

Enovis has a beta of 1.94, indicating that its stock price is 94% more volatile than the S&P 500. Comparatively, Penumbra has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in ENOV or PEN?

98.4% of Enovis shares are held by institutional investors. Comparatively, 88.9% of Penumbra shares are held by institutional investors. 2.4% of Enovis shares are held by insiders. Comparatively, 5.0% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Does the MarketBeat Community believe in ENOV or PEN?

Penumbra received 789 more outperform votes than Enovis when rated by MarketBeat users. Likewise, 80.27% of users gave Penumbra an outperform vote while only 61.70% of users gave Enovis an outperform vote.

Company	Underperform	Outperform
Enovis	Outperform Votes 29 61.70%	Underperform Votes 18 38.30%
Penumbra	Outperform Votes 818 80.27%	Underperform Votes 201 19.73%

Which has higher valuation & earnings, ENOV or PEN?

Penumbra has lower revenue, but higher earnings than Enovis. Enovis is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Enovis	$2.00B	1.27	-$33.26M	-$2.19	-20.84
Penumbra	$1.16B	8.16	$90.95M	$0.86	287.80

Does the media favor ENOV or PEN?

In the previous week, Penumbra had 12 more articles in the media than Enovis. MarketBeat recorded 19 mentions for Penumbra and 7 mentions for Enovis. Enovis' average media sentiment score of 1.30 beat Penumbra's score of 0.81 indicating that Enovis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Enovis	6 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	7 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Do analysts rate ENOV or PEN?

Enovis currently has a consensus target price of $67.00, suggesting a potential upside of 46.77%. Penumbra has a consensus target price of $254.15, suggesting a potential upside of 2.68%. Given Enovis' stronger consensus rating and higher probable upside, equities analysts plainly believe Enovis is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Enovis	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Penumbra	0 Sell rating(s)	4 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.80

Summary

Penumbra beats Enovis on 13 of the 19 factors compared between the two stocks.